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PlantsTargeted genome editing using artiﬁcial nucleases has the potential to accelerate basic research as well as
plant breeding by providing the means to modify genomes rapidly in a precise and predictable manner.
Here we describe the clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated
protein 9 (Cas9) system, a recently developed tool for the introduction of site-speciﬁc double-stranded DNA
breaks. We highlight the strengths and weaknesses of this technology compared with two well-established
genome editing platforms: zinc ﬁnger nucleases (ZFNs) and transcription activator-like effector nucleases
(TALENs). We summarize recent results obtained in plants using CRISPR/Cas9 technology, discuss possible
applications in plant breeding and consider potential future developments.
© 2015 Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Genome editing with site-speciﬁc nucleases allows reverse genetics,
genome engineering and targeted transgene integration experiments to
be carried out in an efﬁcient and precisemanner. It involves the introduc-
tion of targeted DNA double-strand breaks (DSBs) using an engineered
nuclease, stimulating cellular DNA repair mechanisms. Different genomeBiotechnology, RWTH Aachen
el.: +49 241 6085 13451, +49
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icle under the CC BY-NC-ND license (modiﬁcations can be achieved depending on the repair pathway and the
availability of a repair template (Fig. 1). Two different DSB repair
pathways have been deﬁned: non-homologous end joining (NHEJ) and
homologous recombination (HR). In most cases, NHEJ causes random
insertions or deletions (indels), which can result in frameshift mutations
if they occur in the coding region of a gene, effectively creating a gene
knockout. Alternatively, when the DSB generates overhangs, NHEJ can
mediate the targeted introduction of a double-stranded DNA template
with compatible overhangs (Cristea et al., 2013; Maresca et al., 2013).
When a templatewith regions of homology to the sequence surrounding
the DSB is available, the DNA damage can be repaired by HR, and this
mechanism can be exploited to achieve precise gene modiﬁcations orhttp://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Genome editing with site-speciﬁc nucleases. Double-strand breaks induced by a nuclease at a speciﬁc site can be repaired either by non-homologous end joining (NHEJ) or homol-
ogous recombination (HR). (a) Repair by NHEJ usually results in the insertion (green) or deletion (red) of random base pairs, causing gene knockout by disruption. (b) If a donor DNA is
available,which is simultaneously cut by the samenuclease leaving compatible overhangs, gene insertion byNHEJ can also be achieved. (c)HRwith a donorDNA template can be exploited
to modify a gene by introducing precise nucleotide substitutions or (d) to achieve gene insertion.
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strands induces recombination at speciﬁc genomic loci, NHEJ is by far
the most common DSB repair mechanism in most organisms, including
higher plants, and the frequency of targeted integration by HR remains
much lower than random integration (Puchta, 2005). Strategies such as
the overexpression of proteins involved in HR or the use of negative
selection markers outside the homology regions of the insertion cassette
to prevent the survival of random integration events can achieve
moderate improvements in gene targeting efﬁciency (reviewed in
Puchta and Fauser, 2013).Fig. 2. RNA-guided DNA cleavage by Cas9. (a) In the native system, the Cas9 protein (light
blue) is guided by a structure formed by a CRISPR RNA (crRNA, in black), which contains a
20-nt segment determining target speciﬁcity, and a trans-activating CRISPR RNA
(tracrRNA, in red), which stabilizes the structure and activates Cas9 to cleave the target
DNA (protospacer). The presence of a protospacer-adjacent motif (PAM, in yellow), i.e.,
an NGG (or less frequently NAG) sequence directly downstream from the target DNA, is
a prerequisite for DNA cleavage by Cas9. Among the 20 RNA nucleotides determining tar-
get speciﬁcity, the so-called seed sequence of approximately 12nt (in orange) upstreamof
the PAM is thought to be particularly important for the pairing between RNA and target
DNA. (b) Cas9 can be reprogrammed to cleave DNA by a single guide RNA molecule
(gRNA, in green), a chimera generated by fusing the 3′ end of the crRNA to the 5′ end of
the tracrRNA.The CRISPR/Cas9 system
Until 2013, the dominant genome editing tools were zinc ﬁnger
nucleases (ZFNs; Kim et al., 1996) and transcription activator-like
effector nucleases (TALENs, Christian et al., 2010). Both are artiﬁcial
fusion proteins comprising an engineered DNA-binding domain
fused to the nonspeciﬁc nuclease domain of the restriction enzyme
FokI, and they have been used successfully in many organisms
including plants (reviewed in Jankele and Svoboda, 2014; Palpant
and Dudzinski, 2013). The latest ground-breaking technology for
genome editing is based on RNA-guided engineered nucleases,
which already hold great promise due to their simplicity, efﬁciency
and versatility. The most widely used system is the type II clustered
regularly interspaced short palindromic repeat (CRISPR)/Cas9
(CRISPR-associated) system from Streptococcus pyogenes (Jinek
et al., 2012). CRISPR/Cas systems are part of the adaptive immune
system of bacteria and archaea, protecting them against invading
nucleic acids such as viruses by cleaving the foreign DNA in a
sequence-dependent manner. The immunity is acquired by the inte-
gration of short fragments of the invading DNA known as spacers
between two adjacent repeats at the proximal end of a CRISPR
locus. The CRISPR arrays, including the spacers, are transcribed
during subsequent encounters with invasive DNA and are processed
into small interfering CRISPR RNAs (crRNAs) approximately 40 nt in
length, which combine with the transactivating CRISPR RNA
(tracrRNA) to activate and guide the Cas9 nuclease (Barrangou
et al., 2007). This cleaves homologous double-stranded DNA
sequences known as protospacers in the invading DNA (Barrangou
et al., 2007). A prerequisite for cleavage is the presence of a
conserved protospacer-adjacent motif (PAM) downstream of the
target DNA, which usually has the sequence 5′-NGG-3′ (Gasiunaset al., 2012; Jinek et al., 2012) but less frequently NAG (Hsu et al.,
2013). Speciﬁcity is provided by the so-called ‘seed sequence’
approximately 12 bases upstream of the PAM, which must match
between the RNA and target DNA (Fig. 2).
43L. Bortesi, R. Fischer / Biotechnology Advances 33 (2015) 41–52The rise of a genome editing wonder
Although CRISPR arrays were ﬁrst identiﬁed in the Escherichia coli
genome in 1987 (Ishino et al., 1987), their biological function was not
understood until 2005, when it was shown that the spacers were
homologous to viral and plasmid sequences suggesting a role in
adaptive immunity (Bolotin et al., 2005; Mojica et al., 2005; Pourcel
et al., 2005). Two years later, CRISPR arrays were conﬁrmed to provide
protection against invading viruses when combined with Cas genes
(Barrangou et al., 2007). The mechanism of this immune system based
on RNA-mediated DNA targeting was demonstrated shortly thereafter
(Brouns et al., 2008; Deltcheva et al., 2011; Garneau et al., 2010;
Marrafﬁni and Sontheimer, 2008).
The transition of the CRISPR/Cas system from biological phenome-
non to genome engineering tool came about when it was shown that
the target DNA sequence could be reprogrammed simply by changing
20 nucleotides in the crRNA and that the targeting speciﬁcity of the
crRNA could be combinedwith the structural properties of the tracrRNA
in a chimeric single guide RNA (gRNA), thus reducing the system from
three to two components (Jinek et al., 2012; Fig. 2b). Shortly thereafter,
ﬁve independent groups demonstrated that the two-component system
was functional in eukaryotes (human, mouse and zebraﬁsh), indicating
that the other functions of the CRISPR locus genes were supported by
endogenous eukaryotic enzymes (Cho et al., 2013; Cong et al., 2013;
Hwang et al., 2013; Jinek et al., 2013; Mali et al., 2013). Importantly, it
was also shown that multiple gRNAs with different sequences could
be used to achieve high-efﬁciency multiplex genome engineering at
different loci simultaneously (Cong et al., 2013; Mali et al., 2013).
These milestones conﬁrmed that the CRISPR/Cas9 systemwas a simple,
inexpensive and versatile tool for genomeediting, resulting in a ground-
swell of research based on the technique which has become known as
the ‘CRISPR craze’ (Pennisi, 2013).
In August 2013, ﬁve reports were published discussing the ﬁrst
application of CRISPR/Cas9-based genome editing in plants (Feng
et al., 2013; Li et al., 2013; Nekrasov et al., 2013; Shan et al., 2013; Xie
and Yang, 2013). This ﬁrst group of studies already demonstrated
the immense versatility of the technology in the ﬁeld of plant biology
by embracing the model species Arabidopsis thaliana and Nicotiana
benthamiana as well as crops such as rice, by using a range of transfor-
mation platforms (protoplast transfection, agroinﬁltration and
the generation of stable transgenic plants), by targeting both endoge-
nous genes and transgenes and by exploiting both NHEJ and HR to
generate small deletions, targeted insertions and multiplex genome
modiﬁcations. Subsequent work focused on additional crop species
such as sorghum (Jiang et al., 2013b), wheat (Upadhyay et al., 2013;
Wang et al., 2014b) andmaize (Liang et al., 2014). These studies provid-
ed the ﬁrst comparative data concerning aspects such as mutation
efﬁciency, cleavage speciﬁcity, the resolution of locus structure and
the potential to create large chromosomal deletions and also demon-
strated that gRNAs can be expressed under the control of diverse
promoters, including those recognized by RNA polymerase II and III
(Fauser et al., 2014; Feng et al., 2014; Gao et al., 2014; Jiang et al.,
2013b; Mao et al., 2013; Miao et al., 2013; Sugano et al., 2014;
Upadhyay et al., 2013; Zhang et al., 2014; Zhou et al., 2014). The studies
also conﬁrmed that single chimeric gRNAs are more efﬁcient than
separate crRNA and tracrRNA components in plants, just as they are in
other eukaryotes (Miao et al., 2013; Zhou et al., 2014). While early
works described the CRISPR/Cas9-mediated insertion of short
donor sequences (Li et al., 2013; Shan et al., 2013), Schiml et al.
(2014) reported the integration of a 1.8 kb resistance cassette into
the ADH1 locus of A. thaliana by HR. They exploited an in planta
gene targeting strategy, in which both a targeting vector and
targeting locus are activated simultaneously via DSB induction
during plant development (Fauser et al., 2012). Most recently, the
CRISPR/Cas9 system was shown to work in tomato hairy roots
following transformation with Agrobacterium rhizogenes (Ron et al.,2014) and was the ﬁrst genome editing platform used in the fruit
crop sweet orange (Jia and Wang, 2014).
Interestingly, four independent groups have shown that the
CRISPR/Cas9 system can introduce biallelic or homozygous mutations
directly in the ﬁrst generation of rice and tomato transformants,
highlighting the exceptionally high efﬁciency of the system in these
species (Brooks et al., 2014; Shan et al., 2013; Zhang et al., 2014; Zhou
et al., 2014). It was also shown in Arabidopsis, rice and tomato that
the genetic changes induced by Cas9/gRNA were present in the germ
line and segregated normally in subsequent generations without
further modiﬁcations (Brooks et al., 2014; Fauser et al., 2014; Feng
et al., 2014; Jia et al., 2014; Schiml et al., 2014; Zhang et al., 2014;
Zhou et al., 2014). An overview of publications reporting applications
of the CRISPR/Cas9 system in plants is provided in Table 1–3.
A comparison of CRISPR/Cas9, ZFNs and TALENs
ZFNs and TALENs function as dimers and only protein components
are required. Sequence speciﬁcity is conferred by the DNA-binding
domain of each polypeptide and cleavage is carried out by the FokI
nuclease domain. In contrast, the CRISPR/Cas9 system consists of a
single monomeric protein and a chimeric RNA. Sequence speciﬁcity is
conferred by a 20-nt sequence in the gRNA and cleavage is mediated
by the Cas9 protein. The design of ZFNs is considered difﬁcult due to
the complex nature of the interaction between zinc ﬁngers and DNA
and further limitations imposed by context-dependent speciﬁcity
(Sander et al., 2011). Commercially available ZFNs generally perform
better than those designed using publicly available resources but they
are much more expensive (Ramirez et al., 2008). TALENs are easier to
design because there are one-to-one recognition rules between protein
repeats and nucleotide sequences, and their construction has been
simpliﬁed by efﬁcient DNA assembly techniques such as Golden Gate
cloning (Engler et al., 2008). However, TALENs are based on highly
repetitive sequences which can promote homologous recombination
in vivo (Holkers et al., 2013). In comparison, gRNA-based cleavage relies
on a simple Watson–Crick base pairing with the target DNA sequence,
so sophisticated protein engineering for each target is unnecessary,
and only 20 nt in the gRNA need to be modiﬁed to recognize a different
target.
ZFNs and TALENs both carry the catalytic domain of the restriction
endonuclease FokI, which generates a DSB with cohesive overhangs
varying in length depending on the linker and spacer. Cas9 has two
cleavage domains known as RuvC and HNH (Fig. 2), which cleave the
target DNA three nucleotides upstream of the PAM leaving blunt ends
(Jinek et al., 2012). Occasionally, Cas9 produces overhangs of 1–2 nt
in vitro (Gasiunas et al., 2012; Jinek et al., 2012). Deﬁned overhangs
are useful for the precise insertion of DNA molecules with compatible
overhangs, which occurs by NHEJ-mediated ligation (Cristea et al.,
2013; Maresca et al., 2013). As discussed below (Section 6), the
CRISPR/Cas9 system can also be used to create such structures using
the double-nickase approach (Ran et al., 2013).
ZFNs can theoretically target any sequence but in practice the choice
of targets is limited by the availability of modules based on the context-
dependent assembly platform (Sander et al., 2011). A functional ZFN
pair can be prepared for every ~100 bp of DNA sequence on average
using publicly available libraries (Kim et al., 2009). TALEN targets are
limited by the need for a thymidine residue at the ﬁrst position (Doyle
et al., 2012), but not all TALENs work efﬁciently in vivo and some pairs
therefore fail to generate the anticipated mutations, which means that
each TALEN pair must be experimentally validated (Hwang et al.,
2013). In contrast, the only theoretical requirement of the S. pyogenes
CRISPR/Cas9 system is the presence of the NGG (or NAG) PAM motif
downstream of the target sequence. However, imperfectly matched
spacer sequences can result in cleavage at off-target positions, which
means that gRNA sequences must be chosen carefully to avoid such
artifacts thus reducing the number of targets that can be used in
Table 1
CRISPR-Cas9 mediated NHEJ in transient transfection experiments.
Species Transformation
method
Cas9 codon
optimization
Promoters (Cas9,
gRNA)
Target Mutation
frequency
Detection
method
Off-target (no. of sites
analyzed)
Detection
method
Multiplex
(deletion)
Reference
Arabidopsis
thaliana
PEG-protoplast transfection Arabidopsis (with
intron)
CaMV35SPDK,
AtU6
PDS3, FLS2 1.1–5.6% PCR + sequencing Li et al. (2013)
A. thaliana Leaf agroinﬁltration Arabidopsis (with
intron)
CaMV35SPDK,
AtU6
PDS3 2.7% PCR + sequencing Yes (48 bp) Li et al. (2013)
A. thaliana PEG-protoplast transfection Arabidopsis (with
intron)
CaMV35SPDK,
AtU6
RACK1b, RACK1c 2.5–2.7% PCR + sequencing No (1 site) PCR +
sequencing
Li et al. (2013)
A. thaliana Leaf agroinﬁltration C. reinhardtii CaMV35S, AtU6 Co-transfected GFP n.a. Pre-digested PCR
+ RE
Jiang et al. (2013a,
2013b)
Nicotiana
benthamiana
PEG-protoplast transfection Arabidopsis (with
intron)
CaMV35SPDK,
AtU6
PDS3 37.7–38.5% PCR + sequencing Li et al. (2013)
N. benthamiana Leaf agroinﬁltration Arabidopsis (with
intron)
CaMV35SPDK,
AtU6
PDS3 4.8% PCR + sequencing Li et al. (2013)
N. benthamiana Leaf agroinﬁltration Human CaMV35S, AtU6 PDS 1.8–2.4% PCR + RE No (18 sites) PCR + RE Nekrasov et al.
(2013)
N. benthamiana Leaf agroinﬁltration C. reinhardtii CaMV35S, AtU6 Co-transfected GFP n.a. pre-digested PCR
+ RE
Jiang et al. (2013a,
2013b)
N. benthamiana Leaf agroinﬁltration Human CaMV35S,
CaMV35S
PDS 12.7–13.8% Upadhyay et al.
(2013)
Nicotiana
tabacum
PEG-protoplast transfection Tobacco 2xCaMV35S,
AtU6
PDS, PDR6 16.27–20.3% PCR + RE Yes (1.8 kb) Gao et al. (2014)
Oryza sativa PEG-protoplast transfection Rice 2xCaMV35S,
OsU3
PDS, BADH2, MPK2,
Os02g23823
14.5–38.0% PCR + RE Noa (3 sites) PCR + RE Shan et al. (2013)
O. sativa PEG-protoplast transfection Human CaMV35S, OsU3
or OsU6
MPK5 3–8% RE + qPCR and
T7E1 assay
No (2 sites),
Yes (1 site with
a mismatch at
position 12)
RE + PCR Xie and Yang
(2013)
O. sativa PEG-protoplast transfection Rice CaMV35S, OsU6 SWEET14 n.a. pre-digested PCR
+ RE
Jiang et al. (2013a,
2013b)
O. sativa PEG-protoplast transfection Rice ZmUbi, OsU6 KO1, KOL5; CPS4,
CYP99A2; CYP76M5,
CYP76M6
n.a. PCR + sequencing Yes (115, 170,
245 kb)
Zhou et al. (2014)
Triticum
aestivum
PEG-protoplast transfection Rice 2xCaMV35S,TaU6 MLO 28.5% PCR + RE Shan et al. (2013)
T. aestivum PEG-protoplast transfection Plant ZmUbi,TaU6 MLO-A1 36% T7E1 Wang et al. (2014a,
2014b)
T. aestivum Agrotransfection of cells from
immature embryos
Human CaMV35S,
CaMV35S
PDS, INOX 18–22% PCR + sequencing Upadhyay et al.
(2013)
T. aestivum Agrotransfection of cells from
immature embryos
Human CaMV35S,
CaMV35S
INOX PCR + sequencing No* PCR + RE Yes (53 bp) Upadhyay et al.
(2013)
Zea mays PEG-protoplast transfection Rice 2xCaMV35S,
ZmU3
IPK 16.4–19.1% PCR + RE Liang et al. (2014)
Citrus sinensis Leaf agroinﬁltration Human CaMv35S,
CaMV35S
PDS 3.2–3.9% PCR + RE No (8 sites) PCR + RE Jia et al. (2014)
PEG= polyethylenglycol; CaMV35S= promoter of the 35S gene of the cauliﬂower mosaic virus; 2x35SCaMV= 35S promoter with duplicated enhancer; CaMV35SPDK= hybrid promoter, 35S enhancer fused to the maize C4PPDK basal promoter;
AtU6 = A. thaliana U6 promoter; OsU3, U6 = O. sativa U3 or U6 promoters; ZmUbi, U3 = Z. mays ubiquitin or U3 promoters; TaU6 = T. aestivum U6 promoter; PCR = polymerase chain reaction; RE = restriction enzyme digestion.
a If at least 1 mismatch in the 12 nt seed sequence.
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Table 2
CRISPR-Cas9 mediated NHEJ in stable transformants.
Species Transformation method Cas9 codon
optimization
Promoters
(Cas9, gRNA)
Target Mutation frequency Detection method Off-target/detection
method
Multiplex
(deletion)
Transmission
to progeny
Reference
Arabidopsis
thaliana
Agro-transformation by
ﬂoral dip
Human AtUBQ1, AtU6 Co-transfected GUUS 80% (35/44) Surveyor assay Mao et al.
(2013)
A. thaliana Agro-transformation by
ﬂoral dip
Human AtUBQ1, AtU6 TT4, CHLI1, CHL12 38–89% Phenotype, surveyor
assay, sequencing
Yes (230
bp)
Mao et al.
(2013)
A. thaliana Agro-transformation by
ﬂoral dip
Arabidopsis
(Nickase)
PcUBI4-2 ADH1, TT4, RTEL1 0.04% PCR + deep
sequencing
Fauser et al.
(2014)
A. thaliana Agro-transformation by
ﬂoral dip
Arabidopsis PcUBI4-2 ADH1, TT4, RTEL1 26.7% PCR + deep
sequencing
Yes Fauser et al.
(2014)
A. thaliana Agro-transformation by
ﬂoral dip
Arabidopsis
(Nickase)
PcUBI4-2 ADH1 42.8%
(Paired Nickases)
PCR + deep
sequencing
Yes Schiml et al.
(2014)
A. thaliana Agro-transformation by
ﬂoral dip
C. reinhardtii CaMV35S,
AtU6
co-transfected GFP 58% (35/60) GFP ﬂuorescence Yes Jia et al.
(2014)
A. thaliana Agro-transformation by
ﬂoral dip
Human 2xCaMV35S,
AtU6
BRI1, GAI, JAZ1 30%
(6/20)–84%(16/19)
PCR + RE Yes Feng et al.
(2013)
Oryza sativa Particle bombardment of
callus
Rice 2xCaMV35S,
OsU3
OsPDS, OsBADH2 7.1% (9/97)–9.4%
(7/98)
PCR + RE Shan et al.
(2013)
O. sativa Agro-transformation of
callus
Human OsUBQ, OsU6 OsMYB1 50% (10/20) Surveyor assay Mao et al.
(2013)
O. sativa Agro-transformation of
callus
Rice ZmUbi, OsU3 CAO1, LAZY1 83.3%
(25/30)–91.6%(11/12)
PCR + sequencing Miao et al.
(2013)
O. sativa Agro-transformation of
callus
Human CaMV35S,
OsU6
ROC5, SPP, YSA 5% (1/21)–75%
(24/32)
PCR + RE Feng et al.
(2013)
O. sativa Agro-transformation of
callus
Rice 2xCaMV35S,
ZmU3
PDS, PMS3, EPSPS, DERF1, MSH1,
MYB5, MYB1, ROC5, SPP, YSA
21.1–66.7% PCR + sequencing No/whole-genome
sequencing
Yes Yes Zhang
et al.(2014)
O. sativa Agro-transformation of
callus
Plant 2xCaMV35S,
AtU6
BAL 2% (2/94)–16%
(14/90)
PCR + sequencing No (3 sites)/PCR +
sequencing
Xu et al.
(2014)
O. sativa Agro-transformation of
callus
Human 2xCaMV35S,
AtU6
BAL 0% (0/96)–2% (2/96) PCR + sequencing Xu et al.
(2014)
O. sativa Agro-transformation of
callus
Rice ZmUbi, OsU6 SWEET1a-1b-11-13 12.5% (2/16)–100%
(8/8)
T7E1 assay +
sequencing
No (6 sites)/PCR +
sequencing
Yes Zhou et al.
(2014)
Sorghum
bicolor
Agro-transformation of
immature embryos
Monocot OsActin1, OsU6 Co-transfected DsRed 28% (5/18) DsRed ﬂuorescence Jia et al.
(2014)
Solanum
lycopersicum
Hairy root transformation
by A. rhizogenes
Nicotiana CaMV35S,
AtU6
GFP, SHR n.d. RE + PCR; phenotype Ron et al.
(2014)
S. lycopersicum Agro-transformation of
cotyledons
Human 2xCaMV35S,
AtU6
SlAGO7, Solyc08g041770,
Solyc07g021170, Solyc12g044760
75 (6/8)–100%
(29/29, 8/8)
phenotype, PCR +
sequencing
Yes
(90–140
bp)
Yes Brooks et al.
(2014)
N. tabacum Agro-transformation of
leaf discs
Tobacco 2xCaMV35S,
AtU6
PDS, PDR6 82%
(9/11)–88%(14/16)
Phenotype, PCR + RE
sequencing
No (1 site)/PCR +
RE
Yes Gao et al.
(2014)
T. aestivum Particle bombardment of
embryos
Plant ZmUbi, TaU6 MLO-A1 5.6% (4/72) T7E1 Yes Brooks et al.
(2014)
Marchantia
polymorpha
Agro-transformation of
sporelings
Human CaMV35S or
MpEF, MpU6
ARF1 11% (5/45) Phenotype, PCR +
sequencing
Sugano
et al.
(2014)
AtUBQ1, U6= A. thaliana ubiquitin1 or U6 promoter; PcUBI4-2= P. crispum polyubiquitin promoter; CaMV35S= promoter of the 35S gene of the cauliﬂower mosaic virus; 2x35SCaMV=35S promoter with duplicated enhancer; OsUBQ, Actin1, U3,
U6 = O. sativa ubiquitin, actin 1, U3 or U6 promoters; ZmUbi, U3 = Z. mays ubiquitin or U3 promoters; TaU6 = T. aestivum U6 promoter; MpEF =M. polymorpha elongation factor 1α promoter; MpU6 = M. polymorpha U6 promoter; PCR =
polymerase chain reaction; RE = restriction enzyme digestion; T7E1 = T7 endonuclease I assay; n.d. = not determined.
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Table 3
Homologous recombination using the CRISPR system.
Species Transfection method Cas9 codon
optimization
Promoters
(Cas9, gRNA)
Target Exogenous HR template HR
frequency
detection
method
Reference
Arabidopsis
thaliana
Stable Agro-transformation Human AtUBQ1, AtU6 GUUS None (SSA) 11.4% GUS staining Mao et al.
(2013)
A. thaliana Stable Agro-transformation Arabidopsis PcUBI4-2,
AtU6
GUUS,
UGUS
None (SSA, SDSA) n.d. GUS staining Fauser et al.
(2014)
A. thaliana Stable Agro-transformation Arabidopsis
(nickase)
PcUBI4-2,
AtU6
GUUS,
UGUS
None (SSA, SDSA) n.d. GUS staining Fauser et al.
(2014)
A. thaliana Transient PEG-protoplast
transfection
Human 2xCaMV35S,
AtU6
YFFP None (SSA) 18.8% YFP ﬂuorescence Feng et al.
(2013)
A. thaliana Stable Agro-transformation Arabidopsis PcUBI4-2,
AtU6
ADH1 In planta released ds DNA,
1.8 kb +674 and 673 bp
homology arms
0.14%. PCR, phenotype,
sequencing
Schiml et al.
(2014)
Nicotiana
benthamiana
Transient PEG-protoplast
transfection
Arabidopsis
(with intron)
CaMV35SPDK,
AtU6
NbPDS3 ds DNA, 533 + 114 bp
homology arms
10.7% PCR + RE Li et al., 2013
Oryza sativa Transient PEG-protoplast
transfection
Rice 2xCaMV35S,
OsU3
OsPDS,
OsBADH2
ss oligo DNA, 72b 7% RE + PCR + RE Shan et al.
(2013)
O. sativa Transient particle
bombardment of callus
Rice ZmUbi, OsU3 GUUS None (SSA) n.d. GUS staining Miao et al.
(2013)
AtUBQ1, U6= A. thaliana ubiquitin1 or U6 promoter; PcUBI4-2= P. crispum polyubiquitin promoter; 2x35SCaMV= promoter of the 35S gene of the cauliﬂower mosaic viruswith dupli-
cated enhancer; CaMV35SPDK=hybrid promoter, 35S enhancer fused to themaize C4PPDK basal promoter; OsU3=O. sativaU3promoter; ZmUbi= Z.maysubiquitin 3 promoters; PCR
= polymerase chain reaction; RE= restriction enzyme digestion; n.d. = not determined; SSA= single-strand annealing repair pathway; SDSA= synthesis-dependent strand annealing
repair pathway.
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from eight representative plant species (Arabidopsis, Medicago
truncatula, soybean, tomato, Brachypodium distachyon, rice, sorghum
andmaize) has been used topredict speciﬁc gRNA spacerswithminimal
off-target cleavage using data from mammalian systems (Xie et al.,
2014). This identiﬁed 5–12 NGG-PAMs for every 100 bp of genomic
DNA. The total number of PAMs correlated with genome size, but a
greater number of speciﬁc gRNAs was predicted in monocot genomes
compared to dicot genomes when differences in genome size were
taken into account. For all species exceptmaize, itwaspossible to design
speciﬁc gRNAs to target 85–99% of currently annotated transcript units,
with 68–96% of these transcription units containing at least 10 different
targetable NGG-PAM sites. In maize, which has the largest genome
and greatest number of annotated genes among the eight species that
were analyzed, only 30% of the transcription units could be targeted
by speciﬁc gRNAs. The lack of speciﬁc gRNAs for so many maize genes
probably reﬂects the genome complexity (duplication events) and
genomic sequence context. It is therefore anticipated that wheat and
barley, with even larger genomes than maize, may present similar
challenges for CRISPR/Cas9-mediated genome editing (Xie et al., 2014).
In the future, the range of plant genomic sequences amenable to
the CRISPR/Cas system could be expanded by using Cas9 homologs
with different PAM requirements. Furthermore, the use of standard
full-length gRNAs can be limiting because they are usually transcribed
by RNA polymerase III under the control of either the U6 or U3
promoters, which respectively require guanidine and adenosine
residues at the 5′ end for optimal transcription. Because the system
can tolerate mismatches at the 5′ end of the gRNA, this limitation can
be circumvented by choosing targets without considering the identity
of the ﬁrst base or by appending the required nucleotide to the 5′ end
of the gRNA thus producing transcripts that are one nucleotide longer
(Cho et al., 2014; Hwang et al., 2013; Ran et al., 2013; Shan et al.,
2013). Gao and Zhao (2014) used an artiﬁcial gene containing ribozyme
sequences, which can be transcribed from any promoter, generating
gRNAs by self-catalyzed cleavage of the primary transcript in yeast.
The production of gRNAs using an RNA polymerase II promoter and
terminator has also been reported in plants in two independent studies,
eliminating all restrictions at the 5′ end of the transcripts (Jia andWang,
2014; Upadhyay et al., 2013, Table 1). The ability to use RNA polymerase
II regulatory elements for the production of gRNAs offers many intrigu-
ing possibilities, such as the simultaneous differential expression ofmultiple gRNAs usingwell-characterized tissue-speciﬁc, developmental
stage-speciﬁc and inducible promoters.
In terms of comparative performance, the ﬁrst studies using the
CRISPR/Cas9 system for genome editing in mammalian cell lines
and zebraﬁsh embryos showed that the technology was at least as
efﬁcient as ZFNs and TALENs targeting the same sites (Cong et al.,
2013; Hwang et al., 2013) and in some cases even higher (Ding et al.,
2013). Although the CRISPR/Cas9 system is generally efﬁcient, some
gRNAs achieve higher mutation rates than others, and this does not
always depend on the local accessibility of the nuclease complex.
Some guidelines are emerging to predict the efﬁciency of gRNAs. For
example, Wang et al. (2014a) compared several gRNAs targeting the
same gene in a human cell line and looked for trends associated with
targeting efﬁciency. They found that gRNAs with an unusually high or
low GC content tended to be less effective than those with an average
GC content, and that gRNAs targeting the transcribed strand were less
effective than those targeting the non-transcribed strand. They also
found that Cas9 preferentially binds to gRNAs containing purine
residues in the last four positions of the spacer sequence, and that the
efﬁciency of cleavage is inﬂuenced by the afﬁnity between the gRNA
and Cas9. Similar conclusions were drawn during the development of
a web tool to design gRNAs for the effective targeting of mouse and
human genes (Doench et al., 2014).
As in mammals, the CRISPR/Cas9 system has been shown to achieve
high mutation rates in plants, matching or exceeding those obtained
with ZFNs and TALENs (Lozano-Juste and Cutler, 2014). For example, a
comparison of TALENs and CRISPR/Cas9 targeting the same sites in
maize showed 13.1% efﬁciency with CRISPR and 9.1% with TALENs
(Liang et al., 2014). However, it should be noted that the mutation
rate can be inﬂuenced by differences in the target sequences, the
gRNA structure/sequence, the version of Cas9 (codon-optimized
for different species) and the gRNA expression strategy. Furthermore,
the reported mutation rate can depend on the sensitivity of the analyt-
ical method (e.g., T7 endonuclease I or Surveyor assay, PCR/restriction
analysis or PCR/direct sequencing). Therefore, it is not surprising that
reported mutation rates vary even within the same species. For
example, PEG-mediated transfection of rice protoplasts resulted in a
mutation efﬁciency of up to 38% (targeting the PDS gene, Shan et al.,
2013) or 8% (targeting the MPK5 gene, Xie and Yang, 2013). Finally,
CRISPR/Cas9 activity is greatly dependent on the cell type and delivery
method, as is the case for other nucleases. For example, PEG-mediated
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mutation rate of 37.7% in the PDS gene (Li et al., 2013), whereas the
same constructs delivered by agroinﬁltration into whole leaves
achieved a mutation rate of 4.8% in the same gene. It is unclear whether
this ~10-fold change represents differences in transfection efﬁciency,
gRNA/Cas9 expression levels or DNA repair mechanisms in the distinct
cell types.
Advantages of the CRISPR/Cas9 system
Everything that can be achievedwith the CRISPR/Cas9 system can in
principle also be achieved using either ZFNs or TALENs. Nevertheless,
the appearance of such a large number of publications based on the
CRISPR/Cas9 technology in such a short time, including virgin reports
of genome editing in species such as sweet orange (Jia and Wang,
2014), highlights the clear advantages of CRISPR/Cas9 in terms of
simplicity, accessibility, cost and versatility.
Unlike its predecessors, the CRISPR/Cas9 system does not require
any protein engineering steps, making it much more straightforward
to test multiple gRNAs for each target gene. Furthermore, only 20 nt in
the gRNA sequence need to be changed to confer a different target
speciﬁcity, which means that cloning is also unnecessary. Any number
of gRNAs can be produced by in vitro transcription using two comple-
mentary annealed oligonucleotides (Cho et al., 2013). This allows the
inexpensive assembly of large gRNA libraries so that the CRISPR/Cas9
system can be used for high-throughput functional genomics applica-
tions, bringing genome editing within the budget of any molecular
biology laboratory.
Unlike ZFNs and TALENs, the CRISPR/Cas9 system can cleave
methylated DNA in human cells (Hsu et al., 2013), allowing genomic
modiﬁcations that are beyond the reach of the other nucleases (Ding
et al., 2013). Although this aspect has not been speciﬁcally explored
in plants, it is reasonable to assume that the ability to cleave methyl-
ated DNA is intrinsic to the CRISPR/Cas9 system and not dependent
on the target genome. Approximately 70% of CpG/CpNpG sites
are methylated in plants, particularly the CpG islands found in
promoters and proximal exons (Vanyushin and Ashapkin, 2011). The
CRISPR/Cas9 technology is therefore more versatile for genome editing
in plants generally but particularly suitable for monocots with high
genomic GC content such as rice (Miao et al., 2013). Conventional
TALENs cannot cleave DNA containing 5-methylcytosine but methylat-
ed cytosine is indistinguishable from thymidine in the major groove.
Therefore, the repeat that recognizes cytosine can be replaced with a
repeat which recognizes thymidine, generating TALENs that can cleave
methylated DNA albeit at the expense of target speciﬁcity (Deng et al.,
2012; Valton et al., 2012).
The main practical advantage of CRISPR/Cas9 compared to ZFNs and
TALENs is the ease of multiplexing. The simultaneous introduction of
DSBs at multiple sites can be used to edit several genes at the same
time (Li et al., 2013; Mao et al., 2013) and can be particularly useful to
knock out redundant genes or parallel pathways. The same strategy
can also be used to engineer large genomic deletions or inversions by
targeting two widely spaced cleavage sites on the same chromosome
(Li et al., 2013; Upadhyay et al., 2013; Zhou et al., 2014). Multiplex
editing with the CRISPR/Cas9 system simply requires the monomeric
Cas9 protein and any number of different sequence-speciﬁc gRNAs. In
contrast, multiplex editing with ZFNs or TALENs requires separate
dimeric proteins speciﬁc for each target site.
Finally, the open access policy of the CRISPR research community
has promoted the widespread uptake and use of this technology in
contrast, for example, to the proprietary nature of the ZFN platform.
The community provides access to plasmids (e.g., via the non-proﬁt
repository Addgene), web tools for selecting gRNA sequences and
predicting speciﬁcity (e.g., for plant genomes: http://cbi.hzau.edu.cn/
cgi-bin/CRISPR; http://www.genome.arizona.edu/crispr/; and http://
www.rgenome.net/cas-ofﬁnder, http://www.e-crisp.org/E-CRISP/index.html) and hosts active discussion groups (e.g.: https://groups.google.
com/forum/#!forum/crispr). These facilities have encouraged new-
comers to adopt the technology and contributed to the rapid progress in
our understanding of the system and its practical applications.
The speciﬁcity of CRISPR/Cas9
One of the few criticisms of the CRISPR/Cas9 technology is the rela-
tively high frequency of off-target mutations reported in some of the
earlier studies (Cong et al., 2013; Fu et al., 2013; Hsu et al., 2013; Jiang
et al., 2013a; Mali et al., 2013; Pattanayak et al., 2013). Although a 20 nt
sequence in the gRNA was initially considered necessary to determine
speciﬁcity, it was later shown that only the 8–12 nt at the 3′ end (the
seed sequence) is needed for target site recognition and cleavage (Cong
et al., 2013; Jiang et al., 2013a; Jinek et al., 2012), whereas multiple
mismatches in the PAM-distal region can be tolerated, depending on
the total number and arrangement (Fu et al., 2013; Hsu et al., 2013;
Pattanayak et al., 2013). DNA sequences that contain an extra base
(DNA bulge) or a missing base (gRNA bulge) at various locations along
the corresponding gRNA sequence have also been shown to induce
off-target cleavage (Lin et al., 2014). The relaxed speciﬁcity of the
CRISPR/Cas9 complex at non-seed positions in the crRNA spacer
appears to be an intrinsic property that reduces the likelihood of im-
mune system evasion by viruses with point mutations (Semenova
et al., 2011).
Several strategies have been developed to reduce off-target genome
editing, the most important of which is the considered design of the
gRNA. In contrast to ZFNs and TALENs, whose target speciﬁcity is deter-
mined by protein–DNA interactions that are often context-dependent
and unpredictable, the CRISPR/Cas9 system recognizes target sites by
Watson–Crick base pairing allowing off-target sites to be predicted
more reliably by sequence analysis (Cho et al., 2014). The CRISPR/Cas9
system is also easy to reprogram, so gRNAs can be tested for off-target
effects rapidly and inexpensively. For example, Hsu et al. (2013) tested
over 700 sgRNA variants in parallel to gain insight into the issue of spec-
iﬁcity. Based on such comparative studies, a number of guidelines and
online tools have been developed to facilitate the selection of unique
target sites in well-characterized organisms including several plants
(see above). Optimizing nuclease expression is another way to control
speciﬁcity because high concentrations of gRNA and Cas9 can promote
off-target effects (Fujii et al., 2013; Hsu et al., 2013; Pattanayak et al.,
2013).
The FokI nuclease domain of ZFNs and TALENs functions only as a
dimer, with each catalytic monomer (nickase) cleaving a single DNA
strand to create a staggered DSB with overhangs. Similarly, a mutated
version of Cas9 has been produced with a D10A mutation in the RuvC
nuclease domain that converts it into a nickase. The use of two Cas9
nickases can therefore generate offset single-strand nicks that produce
a staggered DSB (Fig. 3a). This strategy increases the number of bases
speciﬁcally recognized for target cleavage, thereby reducing the likeli-
hood of homologous sequences being present elsewhere in the genome.
This strategy can yield precise genome modiﬁcations with efﬁciencies
comparable to the unmodiﬁed enzyme, butwith 50- to 1500-fold great-
er speciﬁcity in human and mouse cells (Cho et al., 2014; Duda et al.,
2014;Mali et al., 2013; Ran et al., 2013; Shen et al., 2014) and Arabidopsis
(Fauser et al., 2014; Schiml et al., 2014). One caveat to this approach is
that two equally efﬁcient gRNAs are needed to make an efﬁcient nickase
pair, potentially limiting the number of target sites given that not all
gRNAs are equivalent in terms of activity (Cho et al., 2014). Furthermore,
each component of a paired nickase system remains catalytically active,
and although nicks are generally repaired with high ﬁdelity, it is not
possible to exclude the possibility of additional off-target mutations.
To address this problem, fusions of catalytically inactive Cas9 and
FokI nuclease have been generated, and these show comparable
efﬁciency to the nickases but substantially higher (N140-fold) speciﬁci-
ty than the wild-type enzyme (Guilinger et al., 2014; Tsai et al., 2014)
Fig. 3. Strategies to increase CRISPR/Cas9 target speciﬁcity. The most important strategy to avoid off-target effects is the design of a speciﬁc gRNA by checking for the presence of homol-
ogous sequences in the genome. Further strategies can then be employed to reduce the risk of off-target cleavage further. (a) A pair of offset Cas9 nickases. The D10Amutation inactivates
theRuvC endonuclease domain so that Cas9 can cleaveonly theDNA strand complementary to the gRNA. The simultaneoususe of twoCas9 nickases binding to sequences onoppositeDNA
strands generates a staggeredDSBwith overhangs. (b) Cas9-FokI fusion proteins. A catalytically inactive Cas9 variant, carrying amutation in both endonuclease domains (RuvC¯HNH¯), can
be fused to the FokI nuclease domain. DNA cleavage by FokI is dependent on dimerization and the enzymemust bind two precisely disposed half-sites on the genome, greatly reducing the
number of possible off-target sequences. (c) Altering the length of the gRNA. Both extending the gRNA by adding two guanidine residues at the 5′ end (left), or shortening it to a truncated
gRNA (truRNA) of only 17 nt (right) can reduce off-target effects.
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version of Cas9must form dimers to cleave DNA (like ZFNs and TALENs)
and must therefore bind two precisely disposed half-sites, greatly
reducing the number of potential off-target sequences.
Altering the length of the gRNA can also minimize non-target
modiﬁcations (Fig. 3c). Guide RNAs with two additional guanidine
residues at the 5′ endwere able to avoid off-target sitesmore efﬁciently
than normal gRNAs but were also slightly less active at on-target sites
(Cho et al., 2014). In contrast, truncated chimeric single guide RNAs
(tru-sgRNAs) 17 nt in length reduced off-target mutations by orders of
magnitude without affecting on-target mutation efﬁciency (Fu et al.,
2014). Truncation may render the RNA-DNA complex more sensitive
to mismatches, perhaps by reducing binding energy at the gRNA-DNA
interface. The tru-sgRNAs and Cas9 nickase approaches can also be
combined, potentially increasing speciﬁcity even further (Fu et al.,
2014).
Off-target effects vary even among different cell types in the same
species. For example, much lower off-target mutation rates were
observed in human pluripotent stem cells compared to cancer cell
lines based on whole-genome sequencing data (Smith et al., 2014;
Veres et al., 2014). The limited data available thus far also suggest that
off-target effects are rare in plants. In rice, Xie andYang (2013) reported
a 1.6% off-target mutation rate (ﬁve times lower than the on-target
mutation rate) in a single off-target sequence carrying a mismatch atposition 11 upstream from the PAM. In contrast, no off-targetmutations
were found in Arabidopsis, N. benthamiana, wheat and sweet orange, or
in an independent study involving rice, when potential off-target sites
with at least a conserved 12-nt seed sequence were investigated
(Feng et al., 2014; Jia and Wang, 2014; Li et al., 2013; Nekrasov et al.,
2013; Shan et al., 2013; Upadhyay et al., 2013; Zhou et al., 2014) even
using whole-genome sequencing (Feng et al., 2014). Although more
data are required before ﬁrm conclusions can be drawn about the off-
target mutation rates in plants, these results already indicate that the
careful selection of speciﬁc gRNA sequences should minimize the risk
of unwanted genome modiﬁcations.
Applications and implications in plant breeding
Plants provide us with food, animal feed, medicines, chemicals,
renewable materials and biofuels. The domestication of plants has
involved the development of strategies to improve the performance of
crops and tailor their properties. Conventional breeding relies on
existing natural genetic variation and extensive back-crossing programs
are necessary to introgress the selected traits into an elite background.
The availability of beneﬁcial alleles in nature therefore limits what can
be achieved using this approach. New alleles can be introduced by
random mutagenesis, but this must be followed by the time-
consuming screening of large populations to identify mutants with
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breeding by allowing the introduction of precise and predictable modi-
ﬁcations directly in an elite background, and the CRISPR/Cas9 system is
particularly beneﬁcial because multiple traits can be modiﬁed
simultaneously.
NHEJ-mediated gene knockouts are the simplest form of targeted
modiﬁcation, and these could be used e.g., to eliminate genes that
negatively affect food quality, to confer susceptibility to pathogens or
to divertmetabolic ﬂux away from valuable end-products. For example,
Wang et al. (2014b) used both TALEN and CRISPR/Cas9 technologies to
target the genes of the mildew-resistance locus (MLO) in wheat and
successfully knocked out all three MLO homoeoalleles, generating
plants resistant to powdery mildew disease. Precise nucleotide
exchanges using oligonucleotide donor sequences could be used to
modify the regulatory sequences upstream of genes that determine
agricultural performance therefore improving crop yields. The insertion
of large sequences by NHEJ or HR would allow the introduction of
transgenes at deﬁned loci that promote high-level transcription and
do not interfere with the activity of endogenous genes.
Site-speciﬁc nucleases also allow targeted molecular trait stacking,
i.e., the addition of several genes in close vicinity to an existing trans-
genic locus. This makes it feasible to introduce multiple traits into
crops with a low risk of segregation, which is difﬁcult to achieve by
classical breeding or even conventional genetic engineering (Ainley
et al., 2013). Once stacking has been achieved, the entire array of
transgenes can be mobilized into other germplasm by crossing because
it behaves as a single locus. It is possible to achieve these aimsusing site-
speciﬁc recombination, but targeted integration using programmable
nucleases combined with precise NHEJ or HR does not leave behind
any footprints associated with the integration method, such as loxP or
attB sequences.
Although the European regulatory framework for genetically modi-
ﬁed crops focuses on the process and not the product (hence two iden-
tical plants produced by conventional mutagenesis and genetic
engineering would be regulated differently under the current guide-
lines), there is hope and conﬁdence that plants altered by the excision
of a few nucleotides using genome editing tools such as CRISPR/Cas9
would not be classiﬁed as genetically modiﬁed organisms (Hartung
and Schiemann, 2014; Li et al., 2012; Podevin et al., 2013). There are
several ways to create transgene-free mutated plants using program-
mable nucleases, including the transient expression of the nuclease
components using agroinﬁltration or viral vectors, the delivery of the
components directly as functional gRNA and Cas9 protein or the
incorporation of the gRNA and Cas9 transgenes on a separate chromo-
some to the targeted locus so that they can be removed by segregation.
Although the speciﬁcity of the CRISPR/Cas9 technology remains to be
investigated in detail, it is already clear that the frequency of off-target
mutations is well below that caused by chemical and physicalmutagen-
esis techniques (Podevin et al., 2013). Indeed, the use of site-speciﬁc
nucleases could remove much of the regulatory burden associated
with transgenic plants by addressing one of themain causes of concern,
namely, the random integration of transgenes and the resulting poten-
tial for unintended effects such as disrupting host metabolism and/or
producing toxic or allergenic compounds. The complex regulatory pro-
cess and the requirement for time-consuming and expensive safety
analysis have resulted in a de facto moratorium on the development
and commercial release of transgenic plants with the exception of
large companies that have the resources to fund long development
programs (Podevin et al., 2013). The potential to introduce transgenes
at a speciﬁc and predetermined chromosomal position using site-
speciﬁc nucleases should all but eliminate the risk of such unpredictable
events.
One further application of CRISPR/Cas9 that is likely to expand in the
future is the targeted insertion of transgenes in the ﬁelds of metabolic
engineering and molecular farming, where plants or plant cells are
used as factories for the production of speciﬁc metabolites or proteins.Currently, both applications rely on random transgene insertion such
that populations of primary transformants must be screened so that
high-performance clones can be selected. This reﬂects the impact of
genomic position effects (where regulatory elements and chromatin
structure surrounding the transgene integration site inﬂuence
transgene expression) and other features of the transgenic locus (e.g.,
transgene copy number, the presence of inverted repeats and truncated
sequences), all of which affect the likelihood of silencing. The establish-
ment of a generic recipient linewith a predetermined and characterized
‘safe harbor locus’ promoting the strong expression of any transgene
and thus a high yield of the corresponding product, would accelerate
the development and possibly the approval of new plant-based produc-
tion lines.Beyond genome editing
The CRISPR/Cas9 system can be used for several purposes in addition
to genome editing, e.g., the ectopic regulation of gene expression,which
can provide useful information about gene functions and can also
be used to engineer novel genetic regulatory circuits for synthetic
biology applications. The external control of gene expression typically
relies on the use of inducible or repressible promoters, requiring the
introduction of a new promoter and a particular treatment (physical
or chemical) for promoter activation or repression. Disabled nucleases
can be used to regulate gene expression because they can still bind to
their target DNA sequence. This is the casewith the catalytically inactive
version of Cas9 which is known as dead Cas9 (dCas9). This protein is
unable to cut DNA (Fig. 4a), but it can still be recruited to speciﬁc DNA
sequences by gRNAs. If it is expressed as a fusion protein with the
transactivation or transrepression domain of a transcription factor, the
precise and reversible transcriptional control of target genes becomes
possible (Gilbert et al., 2013; Maeder et al., 2013b). Piatek et al.
(2014) modulated the transcription of both a reporter construct
and the endogenous PDS gene in N. benthamiana, fusing the dCas9
C-terminus to the EDLL domain and the TAL activation domain to
generate transcriptional activators, and to the SRDX domain from
the ERF transcription factor to generate a repressor. They observed
that transcriptional activity was inﬂuenced by the position of the
gRNA with respect to the transcriptional start site, as well as the
nature of the target strand (sense or antisense). Even naked dCas9
without any effector domains has been shown to repress both
synthetic and endogenous genes through the steric blocking of tran-
scription initiation and elongation, although the degree of repression
was modest in mammalian cells (Qi et al., 2013). The use of dCas9 for
speciﬁc gene regulation provides an alternative approach in species
that currently lack controllable expression systems. Multiple gRNAs
targeting the same promoter also demonstrate synergistic effects, indi-
cating that tuning the level of transcriptional control is possible using
this approach (Bikard and Marrafﬁni, 2013; Piatek et al., 2014; Qi
et al., 2013). Furthermore, multiple gRNAs targeting different
promoters allow the simultaneous inducible regulation of different
genes (Qi et al., 2013). Two independent research groups have already
extended this approach by layering CRISPR regulatory devices based
on either transcriptional activators (Nissim et al., 2014) or repressors
(Kiani et al., 2014) to create functional cascaded circuits. In this context,
another peculiar feature of the CRISPR/Cas9 system is the ability to use
orthogonal Cas9 proteins to separately and simultaneously carry out
genome editing and gene regulation in the same cell (Esvelt et al.,
2013).
The inactive enzymedCas9 can also be used to deliver speciﬁc cargos
to targeted genomic locations (Fig. 4b). For example, dCas9 has been
fused with a ﬂuorescent protein to visualize selected loci in living
cells, providing a useful tool for studying chromosome structure and
dynamics (Anton et al., 2014; Chen et al., 2013). The same approach
has been used to target proteins involved in histone modiﬁcation and
Fig. 4. Applications of the CRISPR/Cas system beyond genome editing. In addition to targeted genome editing, the CRISPR/Cas9 technology is suitable for other interesting applications.
(a) Gene regulation. A catalytically inactive dead Cas9 (dCas9, in light blue) can be fused to either a transcriptional repressor (left) or activator (right). When the dCas9-repressor fusion
is recruited by a gRNA thatmatches the promoter, 5′ untranslated region or coding sequence of an endogenous gene, it can block transcription initiation, elongation or the binding of tran-
scription factors. When the dCas9-activator fusion is targeted to a promoter, the speciﬁc expression of the endogenous gene is induced. (b) Cargo delivery. The catalytically inactive dCas9
can also be exploited as a programmableDNA-binding protein to deliver diverse cargos to speciﬁc genomic locations. For example, fusionwith a greenﬂuorescent protein (left) provides a
tool for visualizing chromosome structure or dynamics, and fusion with a demethylase (right) can be used for targeted epigenome editing. (c) RNA cleavage. The Type III-B CRISPR-Cas
system (e.g., from Pyrococcus furiosus) is composed of nucleases that form the so-called Cmr complex (yellow) and represents a unique RNA silencing system. The Cmr-crRNA complex
targets invading RNA in a PAM-independent process and is able to degrade complementary RNA sequences cleaving them at multiple sites.
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already demonstrated with TAL repeats (Maeder et al., 2013a).
An important general feature of CRISPR/Cas systems that differenti-
ates them from ZFNs and TALENs is their ability to differentially target
either DNA or RNA. The Type III-B CRISPR-Cas system (e.g., from
Pyrococcus furiosus) is a unique RNA silencing system involving the
homology-dependent degradation of complementary RNA in the
presence of engineered crRNA both in vitro and in vivo (Hale et al.,
2009; Hale et al., 2012) (Fig. 4c). Such ﬂexible post-transcriptional
control of gene expression would compensate for the potential pitfalls
of a solely DNA-targeting technology, when the binding of the complex
to the target DNA is hindered either by chromatin structure or by the
presence of other bound proteins, or when the elimination of only one
of several splice variants from a single transcript is desired. Further-
more, such a system would be more speciﬁc than RNA interference
because it would not rely on host factors such as Dicer or the compo-
nents of the RNA-induced silencing complex and should therefore not
cause the silencing of off-target genes.
Final remarks and outlook
The simplicity and accessibility of the CRISPR/Cas9 technology plat-
form provides many advantages over other genome editing methods,
and this means that loss-of-function screening is now feasible and af-
fordable on a genomic scale (Shalem et al., 2014). The availability of
the CRISPR/Cas9 technology will facilitate both forward and reverse ge-
netics and will enhance basic research even in model species such as
Arabidopsis, which already boast extensive (yet incomplete) mutantlibraries. It will allow the growing amount of genomic and systems
biology data to be exploited more comprehensively, speeding up both
gene discovery and trait development in many plant species. Most
information concerning the properties of the CRISPR/Cas9 system is
currently derived from studies in mammals, and although it seems
that many of the ﬁndings can be generalized it is still necessary to
conduct similar studies in plants to ensure that system properties are
translatable to different species. This certainly applies to extended
applications such as orthogonal gene targeting, which have yet to be
tested in plant systems.
Although the CRISPR/Cas9 system is an excellent tool for genome
editing, the extent of off-target mutation needs to be investigated in
more detail as well as the differences in cleavage efﬁciency among
different but perfectly matched targets. The ability to produce and test
multiple gRNAs in parallel and the availability of next-generation
sequencing technologies will provide ample data for the comparison
of the CRISPR/Cas9 system in many different species and cell types.
Furthermore, the structural analysis of Cas9 and its interaction with
gRNA and target DNA will facilitate the development of engineered
nucleases with greater efﬁciency and speciﬁcity (Jinek et al., 2014;
Sternberg et al., 2014). The development of Cas9 proteins requiring
longer PAMs, which would occur less frequently in the genome, would
be likely to reduce off-target effects even further.
Every evolutionary process involving host–pathogen interactions
is an arms race featuring adaptations and counter-adaptations to over-
come the opponent. Therefore, some viruses may well have evolved
anti-CRISPR strategies to evade this bacterial immune system, and
these as yet undiscovered regulators may provide additional tools to
51L. Bortesi, R. Fischer / Biotechnology Advances 33 (2015) 41–52modify and control the activity of the CRISPR/Cas9 system. Given the
large number of researchers working with CRISPR/Cas9 technology
and the speed at which it has developed since the ﬁrst reports of
genome editing only 2 years ago, further advances in our understanding
and control of the system are likely to come rapidly, potentially leading
to the design of a new generation of genome editing tools.
Acknowledgments
This work was funded by the European Research Council Advanced
Grant ‘Future-Pharma’, Grant Number 269110. We would like to thank
Prof. Dr. Stefan Schillberg and Dr. Thomas Rademacher for helpful
discussions, and Dr. Richard M. Twyman for his assistance with editing
the manuscript.
References
AinleyWM, Sastry-Dent L, Welter ME, Murray MG, Zeitler B, Amora R, et al. Trait stacking
via targeted genome editing. Plant Biotechnol J 2013;11:1126–34.
Anton T, Bultmann S, Leonhardt H, Markaki Y. Visualization of speciﬁc DNA sequences in
living mouse embryonic stem cells with a programmable ﬂuorescent CRISPR/Cas sys-
tem. Nucleus 2014;5:163–72.
Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, et al. CRISPR pro-
vides acquired resistance against viruses in prokaryotes. Science 2007;315:1709–12.
Bikard D, Marrafﬁni LA. Control of gene expression by CRISPR-Cas systems. F1000Prime.
Rep 2013;5:47.
Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. Clustered regularly interspaced short palin-
drome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology
2005;151:2551–61.
Brooks C, Nekrasov V, Lippman ZB, Van Eck J. Efﬁcient gene editing in tomato in the ﬁrst
generation using the clustered regularly interspaced short palindromic repeats/
CRISPR-associated9 system. Plant Physiol 2014;166:1292–7.
Brouns SJ, Jore MM, Lundgren M, Westra ER, Slijkhuis RJ, Snijders AP, et al. Small CRISPR
RNAs guide antiviral defense in prokaryotes. Science 2008;321:960–4.
Chen B, Gilbert LA, Cimini BA, Schnitzbauer J, Zhang W, Li GW, et al. Dynamic imaging of
genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 2013;
155:1479–91.
Cho SW, Kim S, Kim JM, Kim JS. Targeted genome engineering in human cells with the
Cas9 RNA-guided endonuclease. Nat Biotechnol 2013;31:230–2.
Cho SW, Kim S, Kim Y, Kweon J, Kim HS, Bae S, et al. Analysis of off-target effects of
CRISPR/Cas-derived RNA-guided endonucleases and nickases. Genome Res 2014;
24:132–41.
Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, et al. Targeting DNA
double-strand breaks with TAL effector nucleases. Genetics 2010;186:757–61.
Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, et al. Multiplex genome engineering
using CRISPR/Cas systems. Science 2013;339:819–23.
Cristea S, Freyvert Y, Santiago Y, Holmes MC, Urnov FD, Gregory PD, et al. In vivo cleavage
of transgene donors promotes nuclease-mediated targeted integration. Biotechnol
Bioeng 2013;110:871–80.
Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, et al. CRISPR RNA
maturation by trans-encoded small RNA and host factor RNase III. Nature 2011;
471:602–7.
Deng D, Yin P, Yan C, Pan X, Gong X, Qi S, et al. Recognition of methylated DNA by TAL
effectors. Cell Res 2012;22:1502–4.
Ding Q, Regan SN, Xia Y, Oostrom LA, Cowan CA, Musunuru K. Enhanced efﬁciency of
human pluripotent stem cell genome editing through replacing TALENs with
CRISPRs. Cell Stem Cell 2013;12:393–4.
Doench JG, Hartenian E, Graham DB, Tothova Z, Hegde M, Smith I, et al. Rational design of
highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat Biotechnol
2014;32:1262–7.
Doyle EL, Booher NJ, Standage DS, Voytas DF, Brendel VP, Vandyk JK, et al. TAL Effector-
Nucleotide Targeter (TALE-NT) 2.0: tools for TAL effector design and target predic-
tion. Nucleic Acids Res 2012;40:W117–22.
Duda K, Lonowski LA, Kofoed-Nielsen M, Ibarra A, Delay CM, Kang Q, et al. High-efﬁciency
genome editing via 2A-coupled co-expression of ﬂuorescent proteins and zinc ﬁnger
nucleases or CRISPR/Cas9 nickase pairs. Nucleic Acids Res 2014;42:e84.
Engler C, Kandzia R, Marillonnet S. A one pot, one step, precision cloning method with
high throughput capability. PLoS One 2008;3:e3647.
Esvelt KM,Mali P, Braff JL, MoosburnerM, Yaung SJ, Church GM. Orthogonal Cas9 proteins
for RNA-guided gene regulation and editing. Nat Methods 2013;10:1116–21.
Fauser F, Roth N, Pacher M, Ilg G, Sanchez-Fernandez R, Biesgen C, et al. In planta gene
targeting. Proc Natl Acad Sci U S A 2012;109:7535–40.
Fauser F, Schiml S, Puchta H. Both CRISPR/Cas-based nucleases and nickases can be used
efﬁciently for genome engineering in Arabidopsis thaliana. Plant J 2014;79:348–59.
Feng Z, Zhang B, Ding W, Liu X, Yang DL, Wei P, et al. Efﬁcient genome editing in plants
using a CRISPR/Cas system. Cell Res 2013;23:1229–32.
Feng Z, Mao Y, Xu N, Zhang B, Wei P, Yang DL, et al. Multigeneration analysis reveals the
inheritance, speciﬁcity, and patterns of CRISPR/Cas-induced gene modiﬁcations in
Arabidopsis. Proc Natl Acad Sci U S A 2014;111:4632–7.Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et al. High-frequency off-target
mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 2013;
31:822–6.
Fu Y, Sander JD, Reyon D, Cascio VM, Joung JK. Improving CRISPR-Cas nuclease speciﬁcity
using truncated guide RNAs. Nat Biotechnol 2014;32:279–84.
Fujii W, Kawasaki K, Sugiura K, Naito K. Efﬁcient generation of large-scale genome-
modiﬁed mice using gRNA and CAS9 endonuclease. Nucleic Acids Res 2013;41:e187.
Gao Y, Zhao Y. Self-processing of ribozyme-ﬂanked RNAs into guide RNAs in vitro and
in vivo for CRISPR-mediated genome editing. J Integr Plant Biol 2014;56:343–9.
Gao J, Wang G, Ma S, Xie X, Wu X, Zhang X, et al. CRISPR/Cas9-mediated targeted
mutagenesis in Nicotiana tabacum. Plant Mol Biol 2014;10:1007. [s11103-014-
0263-0].
Garneau JE, Dupuis ME, Villion M, Romero DA, Barrangou R, Boyaval P, et al. The CRISPR/
Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010;
468:67–71.
Gasiunas G, Barrangou R, Horvath P, Siksnys V. Cas9-crRNA ribonucleoprotein complex
mediates speciﬁc DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad
Sci U S A 2012;109:E2579–86.
Gilbert LA, Larson MH,Morsut L, Liu Z, Brar GA, Torres SE, et al. CRISPR-mediatedmodular
RNA-guided regulation of transcription in eukaryotes. Cell 2013;154:442–51.
Guilinger JP, Thompson DB, Liu DR. Fusion of catalytically inactive Cas9 to FokI nuclease
improves the speciﬁcity of genome modiﬁcation. Nat Biotechnol 2014;32:577–82.
Hale CR, Zhao P, Olson S, Duff MO, Graveley BR, Wells L, et al. RNA-guided RNA cleavage
by a CRISPR RNA-Cas protein complex. Cell 2009;139:945–56.
Hale CR, Majumdar S, Elmore J, Pﬁster N, ComptonM, Olson S, et al. Essential features and
rational design of CRISPR RNAs that function with the Cas RAMP module complex to
cleave RNAs. Mol Cell 2012;45:292–302.
Hartung F, Schiemann J. Precise plant breeding using new genome editing techniques:
opportunities, safety and regulation in the EU. Plant J 2014;78:742–52.
Holkers M, Maggio I, Liu J, Janssen JM, Miselli F, Mussolino C, et al. Differential integrity of
TALE nuclease genes following adenoviral and lentiviral vector gene transfer into
human cells. Nucleic Acids Res 2013;41:e63.
Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et al. DNA targeting
speciﬁcity of RNA-guided Cas9 nucleases. Nat Biotechnol 2013;31:827–32.
HwangWY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD, et al. Efﬁcient genome editing
in zebraﬁsh using a CRISPR-Cas system. Nat Biotechnol 2013;31:227–9.
Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A. Nucleotide sequence of the iap
gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and
identiﬁcation of the gene product. J Bacteriol 1987;169:5429–33.
Jankele R, Svoboda P. TAL effectors: tools for DNA targeting. Brief Funct Genomics 2014;
13:409–19.
Jia H, Wang N. Targeted genome editing of sweet orange using Cas9/sgRNA. PLoS One
2014;9:e93806.
Jia W, Yang B, Weeks DP. Efﬁcient CRISPR/Cas9-mediated gene editing in Arabidopsis
thaliana and inheritance of modiﬁed genes in the T2 and T3 generations. PLoS One
2014;9:e99225.
JiangW, Bikard D, Cox D, Zhang F, Marrafﬁni LA. RNA-guided editing of bacterial genomes
using CRISPR-Cas systems. Nat Biotechnol 2013a;31:233–9.
Jiang W, Zhou H, Bi H, Fromm M, Yang B, Weeks DP. Demonstration of CRISPR/Cas9/
sgRNA-mediated targeted gene modiﬁcation in Arabidopsis, tobacco, sorghum and
rice. Nucleic Acids Res 2013b;41:e188.
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-
RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 2012;337:
816–21.
Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. RNA-programmed genome editing in
human cells. Elife 2013;2:e00471.
Jinek M, Jiang F, Taylor DW, Sternberg SH, Kaya E, Ma E, et al. Structures of Cas9 en-
donucleases reveal RNA-mediated conformational activation. Science 2014;343:
1247997.
Kiani S, Beal J, EbrahimkhaniMR, Huh J, Hall RN, Xie Z, et al. CRISPR transcriptional repres-
sion devices and layered circuits in mammalian cells. Nat Methods 2014;11:723–6.
Kim YG, Cha J, Chandrasegaran S. Hybrid restriction enzymes: zinc ﬁnger fusions to Fok I
cleavage domain. Proc Natl Acad Sci U S A 1996;93:1156–60.
Kim HJ, Lee HJ, Kim H, Cho SW, Kim JS. Targeted genome editing in human cells with zinc
ﬁnger nucleases constructed via modular assembly. Genome Res 2009;19:1279–88.
Li T, Liu B, Spalding MH, Weeks DP, Yang B. High-efﬁciency TALEN-based gene editing
produces disease-resistant rice. Nat Biotechnol 2012;30:390–2.
Li JF, Norville JE, Aach J, McCormack M, Zhang D, Bush J, et al. Multiplex and homologous
recombination-mediated genome editing in Arabidopsis and Nicotiana benthamiana
using guide RNA and Cas9. Nat Biotechnol 2013;31:688–91.
Liang Z, Zhang K, Chen K, Gao C. Targeted mutagenesis in Zea mays using TALENs and the
CRISPR/Cas system. J Genet Genomics 2014;41:63–8.
Lin Y, Cradick TJ, Brown MT, Deshmukh H, Ranjan P, Sarode N, et al. CRISPR/Cas9 systems
have off-target activity with insertions or deletions between target DNA and guide
RNA sequences. Nucleic Acids Res 2014;42:7473–85.
Lozano-Juste J, Cutler SR. Plant genome engineering in full bloom. Trends Plant Sci 2014;
19:284–7.
Maeder ML, Angstman JF, Richardson ME, Linder SJ, Cascio VM, Tsai SQ, et al. Targeted
DNA demethylation and activation of endogenous genes using programmable
TALE-TET1 fusion proteins. Nat Biotechnol 2013a;31:1137–42.
Maeder ML, Linder SJ, Cascio VM, Fu Y, Ho QH, Joung JK. CRISPR RNA-guided activation of
endogenous human genes. Nat Methods 2013b;10:977–9.
Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, et al. RNA-guided human genome
engineering via Cas9. Science 2013;339:823–6.
Mao Y, Zhang H, Xu N, Zhang B, Gou F, Zhu JK. Application of the CRISPR-Cas system for
efﬁcient genome engineering in plants. Mol Plant 2013;6:2008–11.
52 L. Bortesi, R. Fischer / Biotechnology Advances 33 (2015) 41–52Maresca M, Lin VG, Guo N, Yang Y. Obligate ligation-gated recombination (ObLiGaRe):
custom-designed nuclease-mediated targeted integration through nonhomologous
end joining. Genome Res 2013;23:539–46.
Marrafﬁni LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in staph-
ylococci by targeting DNA. Science 2008;322:1843–5.
Miao J, Guo D, Zhang J, Huang Q, Qin G, Zhang X, et al. Targeted mutagenesis in rice using
CRISPR-Cas system. Cell Res 2013;23:1233–6.
Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, Soria E. Intervening sequences of regularly
spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 2005;60:
174–82.
Nekrasov V, Staskawicz B, Weigel D, Jones JD, Kamoun S. Targeted mutagenesis in the
model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease. Nat
Biotechnol 2013;31:691–3.
Nissim L, Perli SD, Fridkin A, Perez-Pinera P, Lu TK. Multiplexed and programmable regu-
lation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human
cells. Mol Cell 2014;54:698–710.
Palpant NJ, Dudzinski D. Zinc ﬁnger nucleases: looking toward translation. Gene Ther
2013;20:121–7.
Pattanayak V, Lin S, Guilinger JP, Ma E, Doudna JA, Liu DR. High-throughput proﬁling of
off-target DNA cleavage reveals RNA-programmed Cas9 nuclease speciﬁcity. Nat
Biotechnol 2013;31:839–43.
Pennisi E. The CRISPR craze. Science 2013;341:833–6.
Piatek A, Ali Z, Baazim H, Li L, Abulfaraj A, Al-Shareef S, et al. RNA-guided transcriptional
regulation in planta via synthetic dCas9-based transcription factors. Plant Biotechnol J
2014. http://dx.doi.org/10.1111/pbi.12284.
Podevin N, Davies HV, Hartung F, Nogue F, Casacuberta JM. Site-directed nucleases: a par-
adigm shift in predictable, knowledge-based plant breeding. Trends Biotechnol 2013;
31:375–83.
Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new re-
peats by preferential uptake of bacteriophage DNA, and provide additional tools for
evolutionary studies. Microbiology 2005;151:653–63.
Puchta H. The repair of double-strand breaks in plants: mechanisms and consequences
for genome evolution. J Exp Bot 2005;56:1–14.
Puchta H, Fauser F. Gene targeting in plants: 25 years later. Int J Dev Biol 2013;57:629–37.
Qi LS, LarsonMH, Gilbert LA, Doudna JA,Weissman JS, Arkin AP, et al. Repurposing CRISPR
as an RNA-guided platform for sequence-speciﬁc control of gene expression. Cell
2013;152:1173–83.
Ramirez CL, Foley JE, Wright DA, Muller-Lerch F, Rahman SH, Cornu TI, et al. Unexpected
failure rates for modular assembly of engineered zinc ﬁngers. Nat Methods 2008;5:
374–5.
Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, et al. Double nicking by
RNA-guided CRISPR Cas9 for enhanced genome editing speciﬁcity. Cell 2013;154:
1380–9.
Ron M, Kajala K, Pauluzzi G, Wang D, Reynoso MA, Zumstein K, et al. Hairy root transfor-
mation using Agrobacterium rhizogenes as a tool for exploring cell type-speciﬁc gene
expression and function using tomato as a model. Plant Physiol 2014;166:455–69.
Sander JD, Dahlborg EJ, Goodwin MJ, Cade L, Zhang F, Cifuentes D, et al. Selection-free
zinc-ﬁnger-nuclease engineering by context-dependent assembly (CoDA). Nat
Methods 2011;8:67–9.
Schiml S, Fauser F, Puchta H. The CRISPR/Cas system can be used as nuclease for in planta
gene targeting and as paired nickases for directed mutagenesis in Arabidopsis
resulting in heritable progeny. Plant J 2014. http://dx.doi.org/10.1111/tpj.12704.Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, et al. Inter-
ference by clustered regularly interspaced short palindromic repeat (CRISPR)
RNA is governed by a seed sequence. Proc Natl Acad Sci U S A 2011;108:
10098–103.
Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, et al. Genome-scale
CRISPR-Cas9 knockout screening in human cells. Science 2014;343:84–7.
Shan Q,Wang Y, Li J, Zhang Y, Chen K, Liang Z, et al. Targeted genomemodiﬁcation of crop
plants using a CRISPR-Cas system. Nat Biotechnol 2013;31:686–8.
Shen B, Zhang W, Zhang J, Zhou J, Wang J, Chen L, et al. Efﬁcient genome modiﬁcation
by CRISPR-Cas9 nickase with minimal off-target effects. Nat Methods 2014;11:
399–402.
Smith C, Gore A, Yan W, Abalde-Atristain L, Li Z, He C, et al. Whole-genome sequencing
analysis reveals high speciﬁcity of CRISPR/Cas9 and TALEN-based genome editing
in human iPSCs. Cell Stem Cell 2014;15:12–3.
Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA. DNA interrogation by the CRISPR
RNA-guided endonuclease Cas9. Nature 2014;507:62–7.
Sugano SS, Shirakawa M, Takagi J, Matsuda Y, Shimada T, Hara-Nishimura I, et al. CRISPR/
Cas9-mediated targetedmutagenesis in the liverwortMarchantia polymorpha L. Plant
Cell Physiol 2014;55:475–81.
Tsai SQ, Wyvekens N, Khayter C, Foden JA, Thapar V, Reyon D, et al. Dimeric CRISPR RNA-
guided FokI nucleases for highly speciﬁc genome editing. Nat Biotechnol 2014;32:
569–76.
Upadhyay SK, Kumar J, Alok A, Tuli R. RNA-guided genome editing for target gene muta-
tions in wheat. G3 (Bethesda). 2013;3:2233–8.
Valton J, Dupuy A, Daboussi F, Thomas S, Marechal A, Macmaster R, et al. Overcoming
transcription activator-like effector (TALE) DNA binding domain sensitivity to cyto-
sine methylation. J Biol Chem 2012;287:38427–32.
Vanyushin BF, Ashapkin VV. DNA methylation in higher plants: past, present and future.
Biochim Biophys Acta 2011;1809:360–8.
Veres A, Gosis BS, Ding Q, Collins R, Ragavendran A, Brand H, et al. Low incidence of
off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem
cell clones detected by whole-genome sequencing. Cell Stem Cell 2014;15:
27–30.
Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR-
Cas9 system. Science 2014a;343:80–4.
Wang Y, Cheng X, Shan Q, Zhang Y, Liu J, Gao C, et al. Simultaneous editing of three
homoeoalleles in hexaploid breadwheat confers heritable resistance to powderymil-
dew. Nat Biotechnol 2014b;32:947–51.
Xie K, Yang Y. RNA-guided genome editing in plants using a CRISPR-Cas system. Mol Plant
2013;6:1975–83.
Xie K, Zhang J, Yang Y. Genome-wide prediction of highly speciﬁc guide RNA spacers for
CRISPR-Cas9-mediated genome editing in model plants and major crops. Mol Plant
2014;7:923–6.
Xu R, Li H, Qin R, Wang L, Li L, Wei P, et al. Gene targeting using the Agrobacterium
tumefaciens-mediated CRISPR-Cas system in rice. Rice (N Y) 2014. 7:5.
Zhang H, Zhang J, Wei P, Zhang B, Gou F, Feng Z, et al. The CRISPR/Cas9 system produces
speciﬁc and homozygous targeted gene editing in rice in one generation. Plant
Biotechnol J 2014;12:797–807.
Zhou H, Liu B, Weeks DP, Spalding MH, Yang B. Large chromosomal deletions and herita-
ble small genetic changes induced by CRISPR/Cas9 in rice. Nucleic Acids Res 2014;42:
10903–14.
